Hydrofarm Holdings Group, Inc. (HYFM) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Hydrofarm Holdings Group, Inc. is a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), primarily serving the U.S. and Canadian markets. The company operates as a single reportable segment.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | Q2 2023 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Net Sales | $54.8 million | $63.1 million | $109.0 million | $125.2 million |
| Gross Profit | $10.9 million | $14.5 million | $21.8 million | $25.9 million |
| Gross Margin | 19.8% | 23.0% | 20.0% | 20.6% |
| Net Loss | $(23.5) million | $(12.9) million | $(36.1) million | $(29.7) million |
| Loss Per Share (Diluted) | $(0.51) | $(0.28) | $(0.79) | $(0.66) |
| Cash and Equivalents | $30.3 million (as of June 30, 2024) | |||
| Total Debt (Principal) | $120.2 million (Term Loan) | |||
| Operating Cash Flow (YTD) | $1.5 million | $1.0 million |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 13.1% in Q2 and 13.0% YTD compared to 2023. Management attributes this to a 10.3% decline in volume/mix and a 2.6% price decrease, driven by agricultural oversupply in the cannabis industry.
- Asset Disposition Loss: A significant non-recurring loss on asset disposition of $11.5 million was recorded in Q2 2024. This resulted from the sale of assets related to the production of durable equipment products (Innovative Growers Equipment) to CM Fabrication, LLC. The company retained the brand and customer relationships but sold the manufacturing assets.
- Restructuring: The company is in the second phase of a restructuring plan initiated in late 2023. Q2 2024 included $0.9 million in restructuring charges, primarily for U.S. manufacturing facility consolidations. Total non-cash charges for this phase through June 2024 reached $9.2 million, largely due to inventory markdowns.
- Margin Compression: Gross margin declined to 19.8% in Q2 2024 from 23.0% in Q2 2023, primarily due to lower productivity in select manufacturing facilities.
Guidance, Outlook, and Risks
- Market Conditions: Management cites continued adverse market conditions due to industry oversupply and decreasing prices for customers' products. They anticipate these conditions may persist.
- Future Charges: The company estimates additional charges associated with the second phase of its restructuring plan or other actions in the second half of 2024 may exceed $2.0 million.
- Cost Savings: The restructuring and asset sale are expected to result in annual cost savings of over $2.0 million and improve profitability on future durable product sales via a new contract manufacturing arrangement.
- Liquidity: The company holds $30.3 million in cash and has approximately $20 million available under its Revolving Credit Facility. Management believes this is sufficient for operations over the next 12 months.
- Nasdaq Listing Risk: The company received notice from Nasdaq on March 14, 2024, regarding non-compliance with the Minimum Bid Price Requirement (stock price below $1.00 for 30 consecutive days). The company has a grace period until September 10, 2024, to regain compliance. Failure to do so could result in delisting.
Investor Verification Checklist
- Nasdaq Compliance: Verify if the stock price has sustained a closing bid of $1.00 or more for 10 consecutive business days to avoid delisting proceedings.
- Asset Sale Proceeds: Confirm the reinvestment of the estimated $6.3 million net proceeds from the asset sale into permitted capital expenditures or debt prepayment as required by the Term Loan.
- Inventory Valuation: Monitor future quarters for additional inventory write-downs given the company's history of markdowns related to the restructuring plan.
- Debt Covenants: Review the company's ability to maintain the fixed charge coverage ratio (1.1x) if excess availability on the Revolving Credit Facility drops below 10% of the commitment.
- Restructuring Execution: Track the realization of the projected $2.0 million+ in annual cost savings from facility consolidations and the new contract manufacturing model.